Long Tail Of Brands Pose Challenge For Indian Pharma Growth: PwC Report
This article was originally published in PharmAsia News
The Indian drug industry may risk losing out if newer methods of drug marketing are not part of their long-term strategies.
You may also be interested in...
Size Is Rewarded When Fostering Brand In India, But Pricing Has To Be Right: Elsevier Business Intelligence Webinar
A rising number of enforcement actions by major drug regulators like the U.S. FDA is slowly making investors cautious about the longer term repercussions on earnings of Indian drug makers.